Revenue: As of FY2025 Q3, the actual value is USD 79.91 M.EPS: As of FY2025 Q3, the actual value is USD -0.03.EBIT: As of FY2025 Q3, the actual value is USD -3.052 M.<h3>Segment Revenue</h3><ul><li>Dispensary: Revenue for the three months ended September 30, 2025, was $65,313, compared to $95,223 for the same period in 2024. For the nine months ended September 30, 2025, revenue was $204,896 compared to $308,554 for the same period in 2024.</li><li>Cultivation and Wholesale: Revenue for the three months ended September 30, 2025, was $14,599, compared to $19,560 for the same period in 2024. For the nine months ended September 30, 2025, revenue was $48,806 compared to $54,030 for the same period in 2024.</li></ul><h3>Operational Metrics</h3><ul><li>Net Loss: Net loss for the three months ended September 30, 2025, was - $14,655, compared to - $1,763 for the same period in 2024. For the nine months ended September 30, 2025, net loss was - $124,247 compared to - $49,974 for the same period in 2024.</li><li>Gross Margin: Gross margin for the three months ended September 30, 2025, was $22,911, compared to $43,810 for the same period in 2024. For the nine months ended September 30, 2025, gross margin was $69,349 compared to $134,399 for the same period in 2024.</li><li>Operating Loss: Operating loss for the three months ended September 30, 2025, was - $12,030, compared to - $5,626 for the same period in 2024. For the nine months ended September 30, 2025, operating loss was - $36,026 compared to - $8,356 for the same period in 2024.</li><li>Selling, General and Administrative Expenses: Expenses for the three months ended September 30, 2025, were $34,941, compared to $49,315 for the same period in 2024. For the nine months ended September 30, 2025, expenses were $105,182 compared to $142,634 for the same period in 2024.</li></ul><h3>Cash Flow</h3><ul><li>Operating Cash Flow: Operating cash flow for the nine months ended September 30, 2025, was - $35,666, compared to - $27,360 for the same period in 2024.</li><li>Investing Cash Flow: Investing cash flow for the nine months ended September 30, 2025, was $35,459, compared to $29,971 for the same period in 2024.</li><li>Financing Cash Flow: Financing cash flow for the nine months ended September 30, 2025, was - $16,827, compared to - $6,878 for the same period in 2024.</li></ul><h3>Future Outlook and Strategy</h3><ul><li>Core Business Focus: The company is reviewing strategic alternatives to reduce leverage and address its capital structure, including potential asset sales, mergers, or other strategic or financial transactions, in light of ongoing operational and financial challenges and the uncertainty of U.S. federal regulatory changes.</li><li>Non-Core Business: The company has committed to divesting its Illinois operations and remaining California operations, which include dispensaries and cultivation/manufacturing facilities.</li><li>Priority: The company aims to obtain sufficient funding or complete strategic transactions on acceptable terms to continue as a going concern. Failure to do so may result in delaying or reducing the scope of activities, extending payment terms with suppliers, liquidating assets, further curtailing planned operations, or ceasing operations entirely.</li></ul>

The Cannabist Company Holdings Inc. | 10-Q: FY2025 Q3 Revenue: USD 79.91 M